Publication | Closed Access

Synthesis and in vitro anticancer activity of 4H-pyrano[2,3-d]pyrimidine−1H-1,2,3-triazole hybrid compounds bearing D-glucose moiety with dual EGFR/HER2 inhibitory activity and induced fit docking study

Molecular PharmacologyMedicinal ChemistryVitro Anticancer ActivityMedicinePharmacological AgentAnti-cancer AgentD-glucose MoietyDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug Discovery